Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin secretion in type 1 diabetes.

Chynna Steele1, William A Hagopian, Stephen Gitelman

  • 1Department of Medicine, Division of Endocrinology, and the Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Diabetes
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A surviving beta cell subpopulation enriched in patients with T1D.

bioRxiv : the preprint server for biology·2026
Same author

Baricitinib and ruxolitinib use through the UK HLH Network.

The Lancet. Rheumatology·2026
Same author

Belantamab mafodotin-associated keratopathy: Clinical outcomes and management from two UK tertiary centres.

British journal of haematology·2026
Same author

New and emerging therapies in type 1 diabetes mellitus.

The Journal of clinical investigation·2026
Same author

Tet2 modulates ER stress responses related to β-cell death and autoimmunity in diabetes.

iScience·2026
Same author

Predicting checkpoint inhibitor-associated autoimmune diabetes: prospects and limitations.

The Journal of clinical investigation·2026

Type 1 diabetes patients retain more insulin secretion at diagnosis than previously thought. Early insulin response patterns predict faster beta-cell loss and disease progression.

Area of Science:

  • Endocrinology
  • Immunology
  • Metabolic Research

Background:

  • Type 1 diabetes involves autoimmune destruction of insulin-producing beta-cells.
  • Predicting the rate of type 1 diabetes progression and understanding insulin secretion changes over time remains challenging.
  • Previous studies on insulin secretion used limited time points and non-physiologic conditions.

Purpose of the Study:

  • To investigate qualitative and quantitative insulin secretion in response to a mixed meal in newly diagnosed type 1 diabetes patients.
  • To track changes in insulin secretion over 24 months in patients with type 1 diabetes.
  • To determine if insulin response patterns correlate with disease progression and glucose control.

Main Methods:

  • Studied insulin secretion to a 4-hour mixed meal in 41 newly diagnosed type 1 diabetes patients.

Related Experiment Videos

  • Followed insulin secretion for 24 months in 20 of these patients.
  • Correlated insulin secretory response with glucose control (HbA1c).

    • Main Results:

    • Newly diagnosed patients showed 52% of control insulin secretion, higher than previously reported.
    • Beta-cell function declined at an average rate of 756 pmol/month, reaching 28% of initial levels after 2 years.
    • An early insulin response (within 45 min) was linked to accelerated insulin secretion loss and faster disease progression.

    Conclusions:

    • Physiologic insulin secretion in type 1 diabetes at diagnosis is greater than previously appreciated.
    • The timing of the insulin response to a meal is a key factor influencing the rate of beta-cell destruction.
    • Qualitative insulin secretion patterns are important determinants of metabolic decompensation in type 1 diabetes.